SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 10.91 |
| Enterprise Value ($M) | 14.79 |
| Book Value ($M) | -7.39 |
| Book Value / Share | -2.90 |
| Price / Book | -1.48 |
| NCAV ($M) | -7.89 |
| NCAV / Share | -3.09 |
| Price / NCAV | -1.38 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -12.17 |
| Return on Assets (ROA) | -1.67 |
| Return on Equity (ROE) | -155.72 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.10 |
| Current Ratio | 1.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.97 |
| Assets | 7.47 |
| Liabilities | 14.86 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -26.26 |
| Net Income | -25.43 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -35.98 |
| Cash from Investing | 0.02 |
| Cash from Financing | 33.41 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| AOBI – American Oriental Bioengineering, Inc. | AOLS – Aeolus Pharmaceuticals, Inc. |
| AOXG – Aoxing Pharmaceutical Company, Inc. | ARDS – Aridis Pharmaceuticals, Inc. |
| ARGNF – argenx SE |
Financial data and stock pages provided by
Fintel.io